264 related articles for article (PubMed ID: 30014611)
1. Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy.
Weiss RB; Vieland VJ; Dunn DM; Kaminoh Y; Flanigan KM;
Ann Neurol; 2018 Aug; 84(2):234-245. PubMed ID: 30014611
[TBL] [Abstract][Full Text] [Related]
2. Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.
Bello L; Flanigan KM; Weiss RB; ; Spitali P; Aartsma-Rus A; Muntoni F; Zaharieva I; Ferlini A; Mercuri E; Tuffery-Giraud S; Claustres M; Straub V; Lochmüller H; Barp A; Vianello S; Pegoraro E; Punetha J; Gordish-Dressman H; Giri M; McDonald CM; Hoffman EP;
Am J Hum Genet; 2016 Nov; 99(5):1163-1171. PubMed ID: 27745838
[TBL] [Abstract][Full Text] [Related]
3. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.
Flanigan KM; Ceco E; Lamar KM; Kaminoh Y; Dunn DM; Mendell JR; King WM; Pestronk A; Florence JM; Mathews KD; Finkel RS; Swoboda KJ; Gappmaier E; Howard MT; Day JW; McDonald C; McNally EM; Weiss RB;
Ann Neurol; 2013 Apr; 73(4):481-8. PubMed ID: 23440719
[TBL] [Abstract][Full Text] [Related]
4.
Kosac A; Pesovic J; Radenkovic L; Brkusanin M; Radovanovic N; Djurisic M; Radivojevic D; Mladenovic J; Ostojic S; Kovacevic G; Kravljanac R; Savic Pavicevic D; Milic Rasic V
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011296
[TBL] [Abstract][Full Text] [Related]
5. Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.
van den Bergen JC; Hiller M; Böhringer S; Vijfhuizen L; Ginjaar HB; Chaouch A; Bushby K; Straub V; Scoto M; Cirak S; Humbertclaude V; Claustres M; Scotton C; Passarelli C; Lochmüller H; Muntoni F; Tuffery-Giraud S; Ferlini A; Aartsma-Rus AM; Verschuuren JJ; 't Hoen PA; Spitali P
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1060-5. PubMed ID: 25476005
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
[TBL] [Abstract][Full Text] [Related]
7. The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
Licandro SA; Crippa L; Pomarico R; Perego R; Fossati G; Leoni F; Steinkühler C
Skelet Muscle; 2021 Jul; 11(1):19. PubMed ID: 34294164
[TBL] [Abstract][Full Text] [Related]
8. Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study.
Bello L; Kesari A; Gordish-Dressman H; Cnaan A; Morgenroth LP; Punetha J; Duong T; Henricson EK; Pegoraro E; McDonald CM; Hoffman EP;
Ann Neurol; 2015 Apr; 77(4):684-96. PubMed ID: 25641372
[TBL] [Abstract][Full Text] [Related]
9. DMD mutation and LTBP4 haplotype do not predict onset of left ventricular dysfunction in Duchenne muscular dystrophy.
Van Dorn CS; Puchalski MD; Weng HY; Bleyl SB; Butterfield RJ; Williams RV
Cardiol Young; 2018 Jul; 28(7):910-915. PubMed ID: 29766838
[TBL] [Abstract][Full Text] [Related]
10. Genetic Modifiers and Phenotype of Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis.
Pascual-Morena C; Cavero-Redondo I; Saz-Lara A; Sequí-Domínguez I; Lucerón-Lucas-Torres M; Martínez-Vizcaíno V
Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451895
[TBL] [Abstract][Full Text] [Related]
11. Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.
Fallon JR; McNally EM
Matrix Biol; 2018 Aug; 68-69():616-627. PubMed ID: 29481844
[TBL] [Abstract][Full Text] [Related]
12. The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy.
Bello L; Sabbatini D; Fusto A; Gorgoglione D; Borin GU; Penzo M; Riguzzi P; Villa M; Vianello S; Calore C; Melacini P; Vio R; Barp A; D'Angelo G; Gandossini S; Politano L; Berardinelli A; Messina S; Vita GL; Pedemonte M; Bruno C; Albamonte E; Sansone V; Baranello G; Masson R; Astrea G; D'Amico A; Bertini E; Pane M; Lucibello S; Mercuri E; Spurney C; Clemens P; Morgenroth L; Gordish-Dressman H; McDonald CM; Hoffman EP; ; Pegoraro E
J Neuromuscul Dis; 2024; 11(2):285-297. PubMed ID: 38363615
[TBL] [Abstract][Full Text] [Related]
13. Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.
Barp A; Bello L; Politano L; Melacini P; Calore C; Polo A; Vianello S; Sorarù G; Semplicini C; Pantic B; Taglia A; Picillo E; Magri F; Gorni K; Messina S; Vita GL; Vita G; Comi GP; Ermani M; Calvo V; Angelini C; Hoffman EP; Pegoraro E
PLoS One; 2015; 10(10):e0141240. PubMed ID: 26513582
[TBL] [Abstract][Full Text] [Related]
14. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice.
Heydemann A; Ceco E; Lim JE; Hadhazy M; Ryder P; Moran JL; Beier DR; Palmer AA; McNally EM
J Clin Invest; 2009 Dec; 119(12):3703-12. PubMed ID: 19884661
[TBL] [Abstract][Full Text] [Related]
15. Modifier genes and their effect on Duchenne muscular dystrophy.
Vo AH; McNally EM
Curr Opin Neurol; 2015 Oct; 28(5):528-34. PubMed ID: 26263473
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms rs2303729, rs10880, and rs1131620 of
Ibarra-Tapia IY; Juárez-Sandoval A; Pérez IT; Cano-Martínez LJ; Sánchez-García S; Ruiz-Batalla JM; Aroche-Reyes IA; García S; Canto P; Mejía DR; Coral-Vázquez RM
Ann Hum Biol; 2022 Dec; 49(7-8):311-316. PubMed ID: 36524797
[TBL] [Abstract][Full Text] [Related]
17. Anti-latent TGFβ binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy.
Demonbreun AR; Fallon KS; Oosterbaan CC; Vaught LA; Reiser NL; Bogdanovic E; Velez MP; Salamone IM; Page PGT; Hadhazy M; Quattrocelli M; Barefield DY; Wood LD; Gonzalez JP; Morris C; McNally EM
Sci Transl Med; 2021 Sep; 13(610):eabf0376. PubMed ID: 34516828
[TBL] [Abstract][Full Text] [Related]
18. Genotype-Specific Interaction of Latent TGFβ Binding Protein 4 with TGFβ.
Lamar KM; Miller T; Dellefave-Castillo L; McNally EM
PLoS One; 2016; 11(2):e0150358. PubMed ID: 26918958
[TBL] [Abstract][Full Text] [Related]
19. Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin.
Zatz M; Pavanello RC; Lazar M; Yamamoto GL; Lourenço NC; Cerqueira A; Nogueira L; Vainzof M
Neuromuscul Disord; 2014 Nov; 24(11):986-9. PubMed ID: 25047667
[TBL] [Abstract][Full Text] [Related]
20. LTBP4 in Health and Disease.
Su CT; Urban Z
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
